Mammoth Biosciences Stock
HealthTechLooking to sell Mammoth Biosciences stock or options?
Mammoth Biosciences is a biotechnology company focused on creating long-term curative therapies and decentralized precision diagnostics. By using its proprietary ultracompact proteins, the company aims to enable in vivo gene editing in challenging-to-access tissues through various nuclease applications, such as base editing, gene writing, and epigenetic editing. This approach allows healthcare professionals to enhance patient outcomes and improve lives.
University of California, Decheng Capital, Tachyon Ventures, Solari Capital, Tectonic Capital, Regeneron Pharmaceuticals, K50 Ventures, Berkeley Frontier Fund, Plum Alley Investments, Boom Capital Ventures, Sixth Street Partners, Wireframe Ventures, Redmile Group, DHVC, 369 Growth Partners, Amazon.com, Mission Bay Capital, Berkeley, 8VC, Kairos HQ, Mission BioCapital, Brook Byers, Plug and Play Tech Center, Verily Life Sciences, Foresite Capital.